Log in

Spectral Medical Stock Price, Forecast & Analysis (OTCMKTS:EDTXF)

-0.04 (-8.16 %)
(As of 11/14/2019 03:36 AM ET)
Today's Range
Now: $0.45
50-Day Range
MA: $0.36
52-Week Range
Now: $0.45
Volume52,300 shs
Average Volume18,203 shs
Market Capitalization$101.62 million
P/E RatioN/A
Dividend YieldN/A
Spectral Medical Inc. focuses on the development and commercialization of treatment for septic shock in North America. The company markets Endotoxin Activity Assay, a rapid diagnostic test for the detection of components of gram negative bacterial cell wall in Europe and Canada; and Toraymyxin, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream in Europe, Canada, and Japan. It also develops, produces, and markets recombinant proteins, antibodies, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies; and develops continuous renal replacement therapy, an open platform for other hemoperfusion cartridges. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was founded in 1991 and is headquartered in Toronto, Canada.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Previous SymbolOTCMKTS:DIAGF



Sales & Book Value

Annual Sales$2.96 million
Book Value$0.02 per share


Net Income$-1,920,000.00


Market Cap$101.62 million
Next Earnings DateN/A
OptionableNot Optionable

Receive EDTXF News and Ratings via Email

Sign-up to receive the latest news and ratings for EDTXF and its competitors with MarketBeat's FREE daily newsletter.

Spectral Medical (OTCMKTS:EDTXF) Frequently Asked Questions

What is Spectral Medical's stock symbol?

Spectral Medical trades on the OTCMKTS under the ticker symbol "EDTXF."

Has Spectral Medical been receiving favorable news coverage?

Media headlines about EDTXF stock have been trending somewhat positive recently, according to InfoTrie. InfoTrie identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Spectral Medical earned a coverage optimism score of 1.7 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Spectral Medical.

Who are some of Spectral Medical's key competitors?

What other stocks do shareholders of Spectral Medical own?

Who are Spectral Medical's key executives?

Spectral Medical's management team includes the folowing people:
  • Dr. Paul M. Walker, Pres, CEO & Director (Age 70)
  • Dr. Gualtiero Guadagni, VP of Sales & Marketing
  • Mr. Richard Wieland, Interim Chief Financial Officer

How do I buy shares of Spectral Medical?

Shares of EDTXF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Spectral Medical's stock price today?

One share of EDTXF stock can currently be purchased for approximately $0.45.

How big of a company is Spectral Medical?

Spectral Medical has a market capitalization of $101.62 million and generates $2.96 million in revenue each year. Spectral Medical employs 18 workers across the globe.View Additional Information About Spectral Medical.

What is Spectral Medical's official website?

The official website for Spectral Medical is http://www.spectraldx.com/.

How can I contact Spectral Medical?

Spectral Medical's mailing address is 135 The West Mall Unit 2, Toronto A6, M9C 1C2. The company can be reached via phone at 416-626-3233 or via email at [email protected]

MarketBeat Community Rating for Spectral Medical (OTCMKTS EDTXF)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  63 (Vote Outperform)
Underperform Votes:  52 (Vote Underperform)
Total Votes:  115
MarketBeat's community ratings are surveys of what our community members think about Spectral Medical and other stocks. Vote "Outperform" if you believe EDTXF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EDTXF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/14/2019 by MarketBeat.com Staff

Featured Article: What is the balance sheet?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel